tradmap

WGS Genedx Holdings Corp.

$68.65 +7.08%

Data as of close

Healthcare · Services-Health Services

Genedx Holdings Corp. (WGS) is a healthcare company in the Services-Health Services industry, with a market capitalization of $2.0 billion. Shares last traded at $68.65, 59.7% below their 52-week high. Over the past year the stock is down 49.9%. Net profit margin is -23.4%, below the peer median of 1.0%. Revenue grew 40.0% year over year.

Market Cap
$2.0B
Shares Out
29.8M
EPS (TTM)
-$3.62
P/E (TTM)*
—
P/S Ratio
4.51
P/B Ratio
8.38
Dividend / Share
—
Dividend Yield
—
52-Week High
$170.41
52-Week Low
$32.24
Volume (venue)
30,022
Avg Vol (3m, venue)
40,109.778

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
+9.49%
1M
-9.81%
3M
-1.89%
6M
+101.32%
YTD
-47.21%
1Y
-49.86%

Daily candles · volume · SMA(20)/SMA(50) · split-adjusted · Databento EQUS.MINI. WGS split history →

Technicals

RSI (14)
48.25
SMA (50)
$78.38
SMA (200)
$71.42
Price vs SMA50
-12.41%
Price vs SMA200
-3.88%
ATR (14)
$5.55

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$454M
Net Income
-$106M
Gross Margin
69.4%
Operating Margin
-20.3%
Net Margin
-23.4%
Return on Equity
-43.5%
Return on Assets
-22.1%
Current Ratio
3.30
Debt / Equity
0.41
Revenue Growth (YoY)
+40.0%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-06-30. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 -$0.60 2026-08-03
Q1 2026 -$2.16 2026-05-04
Q4 2025 (derived) -$0.59 2026-02-23
FY 2025 -$0.73 2026-02-23
Q3 2025 -$0.27 2025-10-28
Q2 2025 $0.36 2025-07-29

Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.

Full earnings history →

Services-Health Services peers

WGS vs 13 industry peers (Services-Health Services), by market cap. Data as of close

P/S vs peers
4.51 / 1.43 med
+215% premium
Net margin vs peers
-23.4% / 1.0% med
below median
1–13 of 13
LFSTLifestance Health Group, Inc.$5.1B101.103.233.2%+0.94%
PRVAPrivia Health Group, Inc.$2.7B97.471.161.2%+0.89%
WGSGenedx Holdings Corp.$2.0B—4.51-23.4%+7.08%
PNTGPennant Group, Inc.$1.4B44.411.302.9%+1.31%
USPHU S Physical Therapy Inc /Nv$1.3B39.361.564.0%-0.08%
INNVInnovAge Holding Corp.$1.2B133.771.180.9%-1.01%
OMDAOmada Health, Inc.$1.1B264.493.681.4%+4.14%
ALPSAlps Group Inc$53M———-0.38%
EUDAEUDA Health Holdings Ltd$30M—4.35-40.7%-1.01%
DCGODocGo Inc.$25M—0.09-65.3%+21.00%
PIIIP3 Health Partners Inc.$13M—0.01-10.1%+0.25%
ATPCAgape ATP Corp$1M———-9.92%
PIIIWP3 Health Partners Inc.————-8.33%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.